FI47098C - Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyyliasetalde hydin valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja analgeettinen vaikutus. - Google Patents

Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyyliasetalde hydin valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja analgeettinen vaikutus.

Info

Publication number
FI47098C
FI47098C FI257170A FI257170A FI47098C FI 47098 C FI47098 C FI 47098C FI 257170 A FI257170 A FI 257170A FI 257170 A FI257170 A FI 257170A FI 47098 C FI47098 C FI 47098C
Authority
FI
Finland
Prior art keywords
indolylacetaldehyde
antipyretic
chlorobenzoyl
inflammatory
methoxy
Prior art date
Application number
FI257170A
Other languages
English (en)
Swedish (sv)
Other versions
FI47098B (fi
Inventor
George Gal
Sletzinger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of FI47098B publication Critical patent/FI47098B/fi
Publication of FI47098C publication Critical patent/FI47098C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/36Oxygen atoms in position 3, e.g. adrenochrome

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI257170A 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyyliasetalde hydin valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja analgeettinen vaikutus. FI47098C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25564263A 1963-02-01 1963-02-01

Publications (2)

Publication Number Publication Date
FI47098B FI47098B (fi) 1973-05-31
FI47098C true FI47098C (fi) 1973-09-10

Family

ID=22969254

Family Applications (9)

Application Number Title Priority Date Filing Date
FI16964A FI46955C (fi) 1963-02-01 1964-01-29 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi
FI257570A FI47101C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen valmistamiseksi.
FI256870A FI47096C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen tert.-butyyliesterin valmistamiseksi.
FI702570A FI47097C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
FI257070A FI47097B (fi) 1963-02-01 1970-09-21
FI257170A FI47098C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyyliasetalde hydin valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja analgeettinen vaikutus.
FI257270A FI47099C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyylietikkaha pon valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja an algeettinen vaikutus.
FI257470A FI47100C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi.
FI257370A FI47185C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-indoli-3-etanolin v almistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja anlgeet tinen vaikutus.

Family Applications Before (5)

Application Number Title Priority Date Filing Date
FI16964A FI46955C (fi) 1963-02-01 1964-01-29 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi
FI257570A FI47101C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen valmistamiseksi.
FI256870A FI47096C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen tert.-butyyliesterin valmistamiseksi.
FI702570A FI47097C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
FI257070A FI47097B (fi) 1963-02-01 1970-09-21

Family Applications After (3)

Application Number Title Priority Date Filing Date
FI257270A FI47099C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyylietikkaha pon valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja an algeettinen vaikutus.
FI257470A FI47100C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi.
FI257370A FI47185C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-indoli-3-etanolin v almistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja anlgeet tinen vaikutus.

Country Status (11)

Country Link
AT (1) AT277992B (fi)
BE (1) BE643268A (fi)
BR (1) BR6456479D0 (fi)
CH (16) CH466283A (fi)
DE (16) DE1695492A1 (fi)
DK (11) DK109334C (fi)
FI (9) FI46955C (fi)
FR (1) FR1559559A (fi)
GB (13) GB1050733A (fi)
NL (1) NL6400813A (fi)
SE (12) SE302463B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU163233B (fi) * 1970-07-31 1973-07-28
WO1989012436A1 (fr) * 1988-06-21 1989-12-28 Vita Zahnfabrik H. Rauter Gmbh & Co. Kg Masse ceramique dispersee
GB9518994D0 (en) * 1995-09-16 1995-11-15 Agrevo Uk Ltd Fungicides

Also Published As

Publication number Publication date
CH457434A (de) 1968-06-15
DE1770132A1 (de) 1971-09-30
DE1695485A1 (de) 1971-04-15
FI47101C (fi) 1973-09-10
DK109334C (da) 1968-04-16
SE302133B (sv) 1968-07-08
DE1695492A1 (de) 1971-04-01
DE1695484A1 (de) 1971-04-15
CH466289A (de) 1968-12-15
DK109514C (da) 1968-05-06
DE1770116A1 (de) 1971-10-14
GB1050733A (fi)
FI47096C (fi) 1973-09-10
CH557815A (de) 1975-01-15
CH457435A (de) 1968-06-15
SE302463B (fi) 1968-07-22
DK112238B (da) 1968-11-25
SE302130B (sv) 1968-07-08
DK112239B (da) 1968-11-25
CH466284A (de) 1968-12-15
DK109562C (da) 1968-05-13
DE1695488A1 (de) 1970-09-17
DK113501B (da) 1969-03-31
SE307948B (fi) 1969-01-27
SE304995B (fi) 1968-10-14
CH464202A (de) 1968-10-31
GB1050734A (fi)
DK112446B (da) 1968-12-16
FI47101B (fi) 1973-05-31
DE1695489A1 (de) 1970-08-13
FI47100B (fi) 1973-05-31
GB1050736A (fi)
DK112313B (da) 1968-12-02
DE1695487A1 (de) 1970-10-01
DK112314B (da) 1968-12-02
DE1770134A1 (de) 1971-09-30
FI47099C (fi) 1973-09-10
GB1050738A (fi)
GB1050740A (fi)
FI47097B (fi) 1973-05-31
FI46955B (fi) 1973-05-02
GB1050731A (fi)
CH457436A (de) 1968-06-15
FI46955C (fi) 1973-08-10
SE320666B (fi) 1970-02-16
DE1770802A1 (de) 1972-02-17
SE320367B (fi) 1970-02-09
SE302132B (sv) 1968-07-08
CH489495A (de) 1970-04-30
GB1050735A (fi)
GB1050739A (fi)
CH466290A (de) 1968-12-15
BR6456479D0 (pt) 1973-09-20
SE317975B (fi) 1969-12-01
FI47185B (fi) 1973-07-02
BE643268A (fi) 1964-07-31
CH466285A (de) 1968-12-15
DE1695486A1 (de) 1971-04-15
FI47185C (fi) 1973-10-10
DK112447B (da) 1968-12-16
CH466288A (de) 1968-12-15
FI47096B (fi) 1973-05-31
FR1559559A (fi) 1969-03-14
CH457437A (de) 1968-06-15
FI47099B (fi) 1973-05-31
DE1695493A1 (de) 1971-04-01
DE1793561A1 (de) 1972-01-20
GB1050730A (fi)
AT277992B (de) 1970-01-12
FI47100C (fi) 1973-09-10
SE307133B (fi) 1968-12-23
GB1050732A (fi)
CH466286A (de) 1968-12-15
FI47097C (fi) 1973-09-10
GB1050737A (fi)
CH464203A (de) 1968-10-31
CH466283A (de) 1968-12-15
CH466287A (de) 1968-12-15
GB1050729A (fi)
NL6400813A (fi) 1964-08-03
DE1470059B1 (de) 1970-01-29
SE320069B (fi) 1970-02-02
FI47098B (fi) 1973-05-31
SE302131B (fi) 1968-07-08
DK111751B (da) 1968-10-07
DE1695490A1 (de) 1971-04-15
GB1050728A (fi)
DE1695491A1 (de) 1971-04-15

Similar Documents

Publication Publication Date Title
DK128353B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.
FI49301C (fi) Menetelmä uusien substituoitujen aminopyridiinien valmistamiseksi, joi lla on tulehduksenvastainen ja kipua lieventävä vaikutus.
FI47107C (fi) Menetelmä penisilliinien valmistamiseksi.
DK112736B (da) Fremgangsmåde til fremstilling af N-(3-aminopyrazinoyl)-benzamidiner.
DK115400B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 3-keto-19-alkyl-androstaner.
IT7830644A0 (it) Picolil-ammine e procedimento per la loro preparazione.
FI44913C (fi) Menetelmä uusien substituoitujen fenyyliamino-1,3-diatsasyklopenteenien-(2) valmistamiseksi, joilla on verenpainetta alentava ja rauhoittava vaikutus
FI47098C (fi) Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyyliasetalde hydin valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja analgeettinen vaikutus.
NL139235B (nl) Werkwijze ter bereiding van een geneesmiddel met antiviruswerking, en van daarvoor geschikte therapeutisch werkzame heterocyclische verbindingen.
FI44002C (fi) Menetelmä tulehduksenvastaisten, kivuntunnetta poistavien ja kuumetta lievittävien, substituoitujen malonihappohydratsidien valmistamiseksi
DK118717B (da) Fremgangsmåde til fremstilling af antidiabetisk virksomme benzensulfonamidopyrimidiner.
NL148058B (nl) Isoxazoolderivaten met anti-pyretische, analgetische, anti-tussieve en/of anti-inflammatoire werking.
DK113717B (da) Analogifremgangsmåde til fremstilling af spiramycin-3-monoacetat og -monopropionat.
IS1694A7 (is) Aðferð til að framleiða benzensulfonylurinsefni.
DK111957B (da) Fremgangsmåde til fremstilling af adamantylderivater af αhydroxy-carboxylsyrer.
DK114126B (da) Fremgangsmåde til fremstilling af substituereded benzamider.
DK120895B (da) Analogifremgangsmåde til fremstilling af benzensulfonylurinstoffer.
FI43994C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 1,2-diaryyli-4-alkyyli-3,5-diokso-pyratsolidiinien valmistamiseksi
FR3418M (fr) Composition analgésique.
FI44911C (fi) Menetelmä uusien, tulehduksia parantavien ja kivuntunnetta poistavien, emäksisesti substituoitujen pseudoindolien valmistamiseksi
FR2521M (fr) Analgésique.
DK112735B (da) Fremgangsmåde til fremstilling af N-(R-phenylsulfonyl)-1-isoquinuclidin-carboxamider.
FI45172C (fi) Menetelmä 17alfa-asyylioksi-6-kloori-1,2alfa-metyleeni-21-fluori- 4,6- pregnadieenien valmistamiseksi.
DK123024B (da) Fremgangsmåde til fremstilling af derivater af L-lysin.
FI51482C (fi) Menetelmä terapeuttisesti käytettävien 3-substituoitujen 1-okso-isoind oliinien ja 2,3-substituoitujen 1-okso-isoindoliinien valmistamiseksi.